RedHill Biopharma (RDHL) Return on Assets (2013 - 2024)

RedHill Biopharma (RDHL) has 12 years of Return on Assets data on file, last reported at 0.04% in Q4 2024.

• Return on Assets for Q4 2024 came in at 0.04%, up 4.0% year-over-year; the trailing twelve-month figure through Dec 2024 was 0.04% (up 4.0% YoY), and the FY2025 annual result was 0.0%, up 1.0% from the prior year.
• Return on Assets improved to 0.04% in Q4 2024 per RDHL's latest filing, from 0.03% in the prior quarter.
• Over five years, Return on Assets peaked at 0.04% in Q4 2024 and troughed at 0.01% in Q1 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2021 frame the typical range for Return on Assets.
• The sharpest annual moves came in 2020 and 2024: Return on Assets decreased 1 bps in 2020, then grew 4 bps in 2024.
• A 5-year view of Return on Assets shows it stood at 0.0% in 2020, then sank by 281 bps to 0.01% in 2021, then grew by 10 bps to 0.0% in 2022, then soared by 59 bps to 0.0% in 2023, then jumped by 2170 bps to 0.04% in 2024.
• Business Quant data shows RDHL's Return on Assets at 0.04% in Q4 2024, 0.03% in Q2 2024, and 0.0% in Q4 2023.